Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country (See Epidemiological Tables on Population Surveys, EMCDDA statistical bulletin).
The age range is from between 15 and 18 to between 59 and 64. Variations in age ranges may slightly influence disparities between countries.
Czech Republic: 2002; 18-34 y. n=1002; 18-24 y. n=389
Denmark: 2000; 16-34 y. n=4141; 16-24 y. n=1754
Germany: 2003; 18-34 y. n=3775; 18-24 y. n=1891
Estonia: 2003; 15-34 y. n=646; 15-24 y. n=329
Greece: 2004; 15-34 y. n=2620; 15-24 y. n=1785
Spain: 2001; 15-34 y. n=6915; 15-24 y. n=3368
France: 2002; 15-34 y. n=724; 15-24 y. n=345
Ireland: 2002/03; 15-34 y. n=; 15-24 y. n=
Italy: 2003; 15-34 y. n=5231; 15-24 y. n=2112
Latvia: 2003; 15-34 y. n=; 15-24 y. n=
Hungary: 2003; 18-34 y. n=2319; 18-24 y. n=943
Netherlands: 2000/01; 15-34 y. n=6687; 15-24 y. n=
Poland: 2002; 16-34 y. n=; 16-24 y. n=
Portugal: 2001; 15-34 y. n=6406; 15-24 y. n=3099
Slovakia: 2002; 18-34 y. n=; 18-24 y. n=
Finland: 2002; 15-34 y. n=1240; 15-24 y. n=614
Sweden: 2004; 18-34 y. n=2985; 18-24 y. n=1171
UK (E&W): 2003/04; 16-34 y. n=8590; 16-24 y. n=5429
Norway: 1999; 15-34 y. n=794; 15-24 y. n=
Sources:
Reitox national reports (2004), taken from population surveys reports or scientific articles. See also standard epidemiological tables in 2005 EMCDDA statistical bulletin.